Perl Highlights Latest CAR T-Cell Therapy Advances – OncLive
OncLive |
Perl Highlights Latest CAR T-Cell Therapy Advances
OncLive OncLive: CAR T-cell therapy was recently named ASCO’s Cancer Advance of the Year. How has this treatment changed the paradigm for hematologic malignancies, such as ALL? Perl: The CD19-directed therapies have really changed that process, whether it’s … |
Phys.Org |
Drug-producing bacteria possible with synthetic biology breakthrough
Phys.Org The researchers have developed a way to efficiently control the distribution of ribosomes – microscopic ‘factories’ inside cells that build proteins that keep the cell alive and functional – to both the synthetic circuit and the host cell. Synthetic … Synthetic Biology Market: By Tool; By Technology; By Application & By Geography – Forecast (2017-2023 …satPRnews (press release) |
|
Potential for CAR T-Cell Therapy for R/R AML
OncLive WT-1 is an internal antigen, so it’s not expressed on the cell surface. You can’t really target it with a typical CAR against an antigen. So, there you have to actually do a TCR-transduced cell. We have some experience led by Aude Chapuis and Phil … |
Wink News |
Fort Myers woman receives stem cells from donor in Germany
Wink News A Fort Myers woman’s cancer is in remission thanks to a stem cell transplant all the way from Europe. Andrea McCaraher was diagnosed with acute lymphoblastic leukemia, childhood leukemia, three years ago. “I didn’t believe that I had leukemia … |